Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elsiglutide for Prevention of Chemotherapy Induced Diarrhea in Colorectal Cancer
NCT01543451Phase 2Completed
- Sponsor
- Helsinn
- Start
- Feb 2012
- Primary completion
- Jan 2013
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of elsiglutide in diarrhea, sponsored by Helsinn. Started Feb 2012; status: completed.
02
Drugs
elsiglutide
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT01543451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01543451.